Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.

Yanna YeGuozhao ZhangZhiqiang LiBiliang ChenHongwei ZhaoYing YangLi WangJilong YaoXiaolin ChenYahong HuangJinghe LangPing LiuChunlin Chen

Published in: Cancer medicine (2023)

Initial treatment influences oncological prognosis for patients with FIGO 2018 stage IIIC cervical cancer. ARH is an alternative treatment for stage IIIC cervical SCC and AC/ASC, and NACT needs to be chosen with caution, moreover, R-CT for AC/ASC requires careful selection.

Keyphrases

computed tomography
magnetic resonance imaging
rectal cancer
minimally invasive
radical prostatectomy
smoking cessation